Differential enzymatic fragmentation

Details Differential enzymatic fragmentation Differential enzymatic fragmentation

2011-03-08

2011-03-08

Bausch, Sarae (Department: 1634)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving nucleic acid

C435S091100, C435S091200, C536S023100, C536S024300

Reexamination Certificate

active

07901880

ABSTRACT:
The present invention provides methods for detecting the presence of methylation at a locus within a population of nucleic acids.

REFERENCES:
patent: 5405760 (1995-04-01), Raleigh et al.
patent: 5786146 (1998-07-01), Herman et al.
patent: 5854033 (1998-12-01), Lizardi
patent: 5871917 (1999-02-01), Duffy
patent: 5912147 (1999-06-01), Stoler et al.
patent: 6200756 (2001-03-01), Herman et al.
patent: 6265171 (2001-07-01), Herman et al.
patent: 6312906 (2001-11-01), Cass et al.
patent: 6331393 (2001-12-01), Laird et al.
patent: 6383754 (2002-05-01), Kaufman et al.
patent: 6498013 (2002-12-01), Velculescu et al.
patent: 6605432 (2003-08-01), Huang
patent: 6777187 (2004-08-01), Makarov et al.
patent: 7459274 (2008-12-01), Lakey et al.
patent: 2002/0123053 (2002-09-01), Luo et al.
patent: 2003/0017454 (2003-01-01), Sukumar et al.
patent: 2003/0099997 (2003-05-01), Bestor
patent: 2003/0129602 (2003-07-01), Huang
patent: 2003/0143599 (2003-07-01), Makarov et al.
patent: 2003/0148290 (2003-08-01), Cottrell
patent: 2003/0165923 (2003-09-01), Li et al.
patent: 2003/0175828 (2003-09-01), Lazar
patent: 2003/0180779 (2003-09-01), Lofton-Day et al.
patent: 2004/0209299 (2004-10-01), Pinter et al.
patent: 2004/0234960 (2004-11-01), Olek et al.
patent: 2005/0153316 (2005-07-01), Jeddeloh et al.
patent: WO 00/26401 (2000-05-01), None
patent: WO 00/43780 (2000-07-01), None
patent: WO 01/68807 (2001-09-01), None
patent: WO 01/75172 (2001-10-01), None
patent: WO 01/96608 (2001-12-01), None
patent: WO 02/18649 (2002-03-01), None
patent: WO 02/38811 (2002-05-01), None
patent: WO 02/059347 (2002-08-01), None
patent: WO 02/103042 (2002-12-01), None
patent: WO 03/002752 (2003-01-01), None
patent: WO 03/023065 (2003-03-01), None
patent: WO 03/025215 (2003-03-01), None
patent: WO 03/027259 (2003-04-01), None
patent: WO 03/050242 (2003-06-01), None
patent: WO 03/066895 (2003-08-01), None
patent: WO 03/076666 (2003-09-01), None
patent: WO 03/078966 (2003-09-01), None
patent: WO 2004/031402 (2004-04-01), None
Burman et al. Am. J. Hum. Genet. 1999, 65:1375-1386.
Trinh et al. (Methods (2001) 25:456-462).
Chu et al. (J. Urology, 2002, vol. 167, pp. 1854-1858).
Humane Genome Center: Laboratory of Genome Database, pp. 128-132.
Humane Genome Center: Laboratory of Genome Structure Analysis, pp. 133-135.
Humane Genome Center: Laboratory DNA. Information Analysis, pp. 136-149.
Humane Genome Center: Laboratory of Sequence Analysis, pp. 150-152.
Humane Genome Center: Laboratory of Functional Genomics, pp. 153-156.
HGM2002; Seventh International Human Genome Meeting, Apr. 2002, 1 page.
Yamada, Yoichi et al.; “A comprehensive analysis of CpG islands reveals methylation imprints on human chromosome 21”; HGM2002 Workshop Abstract No. 13, 1 page.
Yamada, Yoichi et al.; “A comprehensive analysis of CpG islands reveals methylation imprints on human chromosome 21”; HGM2002 Poster No. 89, 1 page.
Yamada, Yoichi et al.; “A comprehensive analysis of Allelic Methylation Status of CpG Islands on Human Chromosome 21q”; 2004, Genome Research, pp. 247-266.
Hatada, I., et al., “A microarray-based method for detecting methylated loci;”J. Hum. Genet., 2002, vol. 47, pp. 448-451.
Chu, Da-Chang et al.; “The use of Real-Time Quantitative Polymerase Chain Reaction to Detect Hypermethylation of the CPG Islands in the Promoter Region Flanking the GSTP1 Gene to Diagnose Prostate Carcinoma”; 2002,The Journal of Urology, vol. 167, pp. 1854-1858.
U.S. Appl. No. 09/430,409, McCombie et al.
U.S. Appl. No. 10/606,502, Martienssen et al.
Adorjan, Peter et al.; “Tumour class prediction and discovery by microarray-based DNA methylation analysis”;Nucleic Acids Research, 2002, vol. 30, No. 5 e21, 9 pages.
Burman Robert W. et al.; “Hypomethylation of an Expanded FMR1 Allele Is Not Associated with a Global DNA Methylation Defect”;Am. J. Hum. Genet., 1999, vol. 65, pp. 1375-1386.
Caldas, Carlos et al.; “Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma”;Nature Genetics, 1994, vol. 8, pp. 27-32.
Craig, B.A. et al.; “Designing Microarrays”;Applied Statistics in Agriculture, pp. 159-164.
Eads, Cindy A. et al.; “MethyLight: a high-throughput assay to measure DNA methylation”;Nucleic Acids Research, 2000, vol. 28, No. 8, e32, 8 pages.
Fraga, Mario F. et al.; “DNA Methylation: A Profile of Methods and Applications”; 2002,BioTechniques, vol. 33, pp. 632-649.
Frigola, Jordi et al.; Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS);Nucleic Acids Research, 2002, vol. 30, No. 7, e28, 7 pages.
Genc, B. et al.; “Identification of disease associated genes and tumour class prediction by genome wide microarray-based DNA methylation scanning”;The American Journal of Human Genetics, 2001, vol. 69, No. 4, 1 page abstract.
Hatada, Izuho et al.; “A microarray-based method for detecting methylated loci”;J. Hum. Genet, 2002, Vo. 47, pp. 448-451.
Herman, James G. et al.; “Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands”;Proc. Natl. Acad. Sci., 1996, vol. 93, pp. 9821-9826.
Huang, Tim Hui-Ming et al.; “Methylation profiling of CpG islands in human breast cancer cells”;Human Molecular Genetics, 1999, vol. 8, No. 3, pp. 459-470.
Kinzler, Kenneth W. et al.; “Whole genome PCR: application to the identification of sequences bound by gene regulatory proteins”; 1989,Nucleic Acids Research, vol. 17, No. 10, pp. 3645-3653.
Lewin, Jorn et al.; “Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates”; 2004,Bioinformatics, vol. 20, No. 0, pp. 1-8.
Li, Long-Cheng et al.; “MethPrimer: designing promers for methylation PCRs”; 2002,Bioinformatics, vol. 18, No. 11, pp. 1427-1431.
McClelland, Michael et al.; “Effect of site-specific modification on restriction endonucleases and DNA modification methyltransferases”;Nucleic Acids Research, 1994, vol. 22, No. 17, pp. 3640-3659.
McrBC—M0272—NEB Restriction Endonucleases; http://www.neb.com
eb/products/res—enzymes/272.html, 3 pages.
“McrBC”; Technical Bulletin, 2001,New England Biolabs, Inc., 2 pages.
Okamoto, Keisei et al.; “Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis”;Proc. Natl. Acad. Sci., 1997, vol. 94, pp. 5367-5371.
Schutte, Mieke et al.; “Abrogation of the Rb/p16 Tumor-suppressive Pathway in Virtually All Pancreatic Carcinomas”;Cancer Research, 1997, vol. 57, pp. 3126-3130.
Singal, Rakesh et al.; “Microsoft Word Macro for Analysis of Cytosine Methylation by the Bisulfite Deamination Reaction”; 2001,BioTechniques, vol. 30, pp. 116-120.
Steigerwald, Sabine D. et al.; “Ligation-mediated PCR improves the sensitivity of methylation analysis by restriction enzymes and detection of specific DNA strand breaks”;Nucleic Acids Research, 1990, vol. 18, No. 6, pp. 1435-1439.
Tompa, Rachel et al.; “Genome-Wide Profiling of DNA Methylation Reveals Transposon Targets of Chromomethylase3”;Current Biology, 2002, vol. 12, pp. 65-68.
Toyota, Minoru et al.; “Identification of Differentially Methylated Sequences in Colorectal Cancer by Methylated CpG Island Amplification”;Cancer Research, 1999, vol. 59, pp. 2307-2312.
Wang, C.H. et al.; “Autism DNA methylation profiling using CpG microarrays”;The American Journal of Human Genetics, 2001, vol. 69, No. 4, 1 page abstract.
Wei, Susan H. et al.; “Methylation Microarray Analysis of Late-Stage Ovarian Carcinomas Distinguishes Progression-free Survival in Patients and Identifies Candidate Epigenetic Markers”;Clinical Cancer Research, 2002, vol. 8, pp. 2246-2252.
Yan, Pearlly S. et al. “CpG Island Arrays: An Application toward Deciphering Epigenetic Signa

Affiliated with

Also associated with

Rating

Differential enzymatic fragmentation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Differential enzymatic fragmentation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Differential enzymatic fragmentation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2707328